Boussard & Gavaudan Investment Management LLP bought a new position in The Procter & Gamble Company (NYSE:PG – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 160,390 shares of the company’s stock, valued at approximately $27,765,000. Procter & Gamble comprises about 2.5% of Boussard & Gavaudan Investment Management LLP’s investment portfolio, making the stock its 11th largest holding.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Quent Capital LLC raised its holdings in Procter & Gamble by 2.0% during the first quarter. Quent Capital LLC now owns 10,684 shares of the company’s stock valued at $1,733,000 after buying an additional 206 shares in the last quarter. Koesten Hirschmann & Crabtree INC. lifted its holdings in Procter & Gamble by 9.0% in the 1st quarter. Koesten Hirschmann & Crabtree INC. now owns 2,124 shares of the company’s stock worth $345,000 after purchasing an additional 176 shares during the last quarter. Community Trust & Investment Co. boosted its position in Procter & Gamble by 0.7% during the first quarter. Community Trust & Investment Co. now owns 124,490 shares of the company’s stock worth $20,199,000 after purchasing an additional 864 shares during the period. Dodds Wealth LLC bought a new stake in Procter & Gamble during the first quarter worth approximately $213,000. Finally, Invst LLC grew its holdings in Procter & Gamble by 7.8% during the first quarter. Invst LLC now owns 14,707 shares of the company’s stock valued at $2,362,000 after purchasing an additional 1,070 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the transaction, the insider now directly owns 11,566 shares of the company’s stock, valued at $1,954,538.34. This trade represents a 52.53 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO R. Alexandra Keith sold 1,992 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total transaction of $338,640.00. Following the completion of the sale, the chief executive officer now owns 13,783 shares of the company’s stock, valued at approximately $2,343,110. This represents a 12.63 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 35,233 shares of company stock worth $6,024,234. Insiders own 0.18% of the company’s stock.
Procter & Gamble Stock Up 0.0 %
Procter & Gamble (NYSE:PG – Get Free Report) last released its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business’s quarterly revenue was down .6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.83 EPS. On average, sell-side analysts forecast that The Procter & Gamble Company will post 6.96 earnings per share for the current year.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.24%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s payout ratio is 69.48%.
Wall Street Analyst Weigh In
Several analysts recently issued reports on the stock. DZ Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price objective for the company in a report on Thursday, August 29th. JPMorgan Chase & Co. lifted their target price on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. DA Davidson upgraded Procter & Gamble from a “neutral” rating to a “buy” rating and raised their target price for the stock from $160.00 to $209.00 in a research report on Monday. Morgan Stanley upped their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research report on Monday, October 21st. Finally, Barclays lowered shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 target price on the stock. in a report on Monday, September 30th. Eight investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $180.45.
View Our Latest Stock Report on PG
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- How to Calculate Options Profits
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Short Selling: How to Short a Stock
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- How to Invest in Insurance Companies: A Guide
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.